{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:39:22Z","timestamp":1771634362887,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T00:00:00Z","timestamp":1627084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["1161078"],"award-info":[{"award-number":["1161078"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["1200908"],"award-info":[{"award-number":["1200908"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["1161078"],"award-info":[{"award-number":["1161078"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["1200908"],"award-info":[{"award-number":["1200908"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008736","name":"Fondo de Fomento al Desarrollo Cientifico y Tecnologico","doi-asserted-by":"publisher","award":["1161078"],"award-info":[{"award-number":["1161078"]}],"id":[{"id":"10.13039\/501100008736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008736","name":"Fondo de Fomento al Desarrollo Cientifico y Tecnologico","doi-asserted-by":"publisher","award":["1200908"],"award-info":[{"award-number":["1200908"]}],"id":[{"id":"10.13039\/501100008736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002848","name":"Comision Nacional de Investigacion Cientifica y Tecnologica","doi-asserted-by":"publisher","award":["1161078"],"award-info":[{"award-number":["1161078"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002848","name":"Comision Nacional de Investigacion Cientifica y Tecnologica","doi-asserted-by":"publisher","award":["1200908"],"award-info":[{"award-number":["1200908"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1161078"],"award-info":[{"award-number":["1161078"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1200908"],"award-info":[{"award-number":["1200908"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biopha.2021.111968","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T06:24:22Z","timestamp":1627712662000},"page":"111968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Increased P2\u00d72 receptors induced by amyloid-\u03b2 peptide participates in the neurotoxicity in alzheimer\u2019s disease"],"prefix":"10.1016","volume":"142","author":[{"given":"Pamela A.","family":"Godoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Mennickent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Cuchillo-Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Ram\u00edrez-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiare","family":"Silva-Grecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Panes-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricio","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"S\u00e1ez-Valero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Fuentealba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2021.111968_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.biopha.2021.111968_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0166-2236(00)02031-2","article-title":"Alzheimer\u2019s disease-do tauists and baptists finally shake hands?","volume":"25","author":"Mudher","year":"2002","journal-title":"TRENDS Neurosci."},{"issue":"4","key":"10.1016\/j.biopha.2021.111968_bib3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3233\/JAD-2012-120229","article-title":"Synaptic silencing and plasma membrane dyshomeostasis induced by amyloid-beta peptide are prevented by Aristotelia chilensis enriched extract","volume":"31","author":"Fuentealba","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.biopha.2021.111968_bib4","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1074\/jbc.M109.030023","article-title":"\u03b2-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure","volume":"285","author":"Parodi","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2021.111968_bib5","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1371\/journal.pone.0011820","article-title":"Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property","volume":"5","author":"Sepulveda","year":"2010","journal-title":"PloS One"},{"issue":"4\u20135","key":"10.1016\/j.biopha.2021.111968_bib6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuropharm.2010.07.012","article-title":"ADDLs and the signaling web that leads to Alzheimer\u2019s disease","volume":"59","author":"Krafft","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2021.111968_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuropharm.2015.04.005","article-title":"ATP leakage induces P2XR activation and contributes to acute synaptic excitotoxicity induced by soluble oligomers of beta-amyloid peptide in hippocampal neurons","volume":"100","author":"S\u00e1ez-Orellana","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2021.111968_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00702-017-1820-x","article-title":"Amyloid \u03b2 oligomers (A\u03b2Os) in Alzheimer\u2019s disease","volume":"125","author":"Mroczko","year":"2018","journal-title":"J. Neural Transm."},{"issue":"44","key":"10.1016\/j.biopha.2021.111968_bib9","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.R800019200","article-title":"Amyloid precursor protein trafficking, processing, and function","volume":"283","author":"Thinakaran","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2021.111968_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrn.2017.29","article-title":"Not just amyloid: physiological functions of the amyloid precursor protein family","volume":"18","author":"M\u00fcller","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"30","key":"10.1016\/j.biopha.2021.111968_bib11","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.1021\/bi9906827","article-title":"Cleavage of Alzheimer\u2019s amyloid precursor protein by \u03b1-secretase occurs at the surface of neuronal cells","volume":"38","author":"Parvathy","year":"1999","journal-title":"Biochemistry"},{"issue":"26","key":"10.1016\/j.biopha.2021.111968_bib12","doi-asserted-by":"crossref","first-page":"17386","DOI":"10.1016\/S0021-9258(17)32449-3","article-title":"Evidence that production and release of amyloid beta-protein involves the endocytic pathway","volume":"269","author":"Koo","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.111968_bib13","doi-asserted-by":"crossref","first-page":"31261","DOI":"10.1074\/jbc.M304122200","article-title":"Rab5-stimulated Up-regulation of the Endocytic Pathway Increases Intracellular \u03b2-Cleaved Amyloid Precursor Protein Carboxyl-terminal Fragment Levels and A\u03b2 Production","volume":"278","author":"Grbovic","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2021.111968_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1073\/pnas.90.2.567","article-title":"Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum","volume":"90","author":"Arispe","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9","key":"10.1016\/j.biopha.2021.111968_bib15","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/jnr.22679","article-title":"Synaptic failure and adenosine triphosphate imbalance induced by amyloid-beta aggregates are prevented by blueberry-enriched polyphenols extract","volume":"89","author":"Fuentealba","year":"2011","journal-title":"J. Neurosci. Res"},{"issue":"23","key":"10.1016\/j.biopha.2021.111968_bib16","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1093\/hmg\/ddr381","article-title":"Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer\u2019s disease","volume":"20","author":"Calkins","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.biopha.2021.111968_bib17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/emm.2007.89","article-title":"ATP released from beta-amyloid-stimulated microglia induces reactive oxygen species production in an autocrine fashion","volume":"39","author":"Kim","year":"2007","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.111968_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","article-title":"beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity","volume":"12","author":"Mattson","year":"1992","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2021.111968_bib19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0306-4522(02)00097-0","article-title":"The mechanisms of neuronal death produced by mitochondrial toxin 3-nitropropionic acid: the roles of N-methyl-D-aspartate glutamate receptors and mitochondrial calcium overload","volume":"112","author":"Lee","year":"2002","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.biopha.2021.111968_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11302-015-9493-0","article-title":"P2X ion channel receptors and inflammation","volume":"12","author":"Burnstock","year":"2016","journal-title":"Purinergic Signal."},{"issue":"19","key":"10.1016\/j.biopha.2021.111968_bib21","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1523\/JNEUROSCI.23-19-07426.2003","article-title":"ATP modulation of excitatory synapses onto interneurons","volume":"23","author":"Khakh","year":"2003","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111968_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuron.2012.09.024","article-title":"Neuromodulation by extracellular ATP and P2X receptors in the CNS","volume":"76","author":"Khakh","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2021.111968_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.phrs.2015.06.009","article-title":"Modulation of the neuronal network activity by P2X receptors and their involvement in neurological disorders","volume":"101","author":"S\u00e1ez-Orellana","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.biopha.2021.111968_bib24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s12272-010-1006-7","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"33","author":"Lee","year":"2010","journal-title":"Arch. Pharmacal Res."},{"issue":"1330","key":"10.1016\/j.biopha.2021.111968_bib25","article-title":"Exploring the role of P2X receptors in Alzheimer\u2019s disease","volume":"10","author":"Godoy","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111968_bib26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.neuropharm.2017.10.027","article-title":"P2X receptor overexpression induced by soluble oligomers of amyloid beta peptide potentiates synaptic failure and neuronal dyshomeostasis in cellular models of Alzheimer\u2019s disease","volume":"128","author":"S\u00e1ez-Orellana","year":"2018","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.biopha.2021.111968_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11302-012-9314-7","article-title":"Molecular and functional properties of P2X receptors\u2014recent progress and persisting challenges","volume":"8","author":"Kaczmarek-H\u00e1jek","year":"2012","journal-title":"Purinergic Signal."},{"issue":"4","key":"10.1016\/j.biopha.2021.111968_bib28","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2021.111968_bib29","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1074\/jbc.M507735200","article-title":"Fe65 interacts with P2\u00d72 subunits at excitatory synapses and modulates receptor function","volume":"281","author":"Masin","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2021.111968_bib30","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1074\/jbc.274.12.7952","article-title":"Regulation of \u03b2-amyloid secretion by FE65, an amyloid protein precursor-binding protein","volume":"274","author":"Sabo","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2021.111968_bib31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3233\/JAD-180945","article-title":"17 oxo sparteine and lupanine, obtained from cytisus scoparius, exert a neuroprotection against soluble oligomers of amyloid-\u03b2 toxicity by nicotinic acetylcholine receptors","volume":"67","author":"Gavilan","year":"2019","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2021.111968_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00005072-199405000-00012","article-title":"Interlaboratory comparison of neuropathology assessments in Alzheimer\u2019s disease: a study of the Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD)","volume":"53","author":"Mirra","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111968_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111968_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00401-009-0485-4","article-title":"Assessment of \u03b2-amyloid deposits in human brain: a study of the BrainNet Europe Consortium","volume":"117","author":"Alafuzoff","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2021.111968_bib35","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3389\/fphar.2020.00709","article-title":"Changes in PGC\u20101\u03b1\/SIRT1 signaling impact on mitochondrial homeostasis in amyloid-beta peptide toxicity model","volume":"11","author":"Panes","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111968_bib36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbr.2011.12.021","article-title":"Cognitive phenotyping of amyloid precursor protein transgenic J20 mice","volume":"228","author":"Karl","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111968_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-510X(02)00087-4","article-title":"N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer\u2019s disease","volume":"200","author":"Bi","year":"2002","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111968_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0169-328X(00)00023-1","article-title":"Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer\u2019s disease","volume":"76","author":"Holsinger","year":"2000","journal-title":"Mol. Brain Res."},{"issue":"9","key":"10.1016\/j.biopha.2021.111968_bib39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/00005072-199909000-00011","article-title":"Distribution of active glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) in brains staged for Alzheimer disease neurofibrillary changes","volume":"58","author":"Pei","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5527","key":"10.1016\/j.biopha.2021.111968_bib40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1126\/science.1058783","article-title":"A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60","volume":"293","author":"Cao","year":"2001","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biopha.2021.111968_bib41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/acel.12183","article-title":"Upregulation of PGC\u20101\u03b1 expression by A lzheimer\u2019s disease\u2010associated pathway: presenilin 1\/amyloid precursor protein (APP)\/intracellular domain of APP","volume":"13","author":"Robinson","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.biopha.2021.111968_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.physiol.010908.163119","article-title":"Transcriptional control of mitochondrial biogenesis and function","volume":"71","author":"Hock","year":"2009","journal-title":"Annu. Rev. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2021.111968_bib43","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(91)90316-Q","article-title":"rab5 controls early endosome fusion in vitro","volume":"64","author":"Gorvel","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2021.111968_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105253","article-title":"Purinergic signaling orchestrating neuron-glia communication","volume":"162","author":"Agostinho","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111968_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/tcmj.tcmj_144_20","article-title":"Modulation of microglia activation and Alzheimer\u2019s disease: CX3 chemokine ligand 1\/CX3CR and P2\u00d77R signaling","volume":"33","author":"Suresh","year":"2021","journal-title":"Tzu Chi Med. J."},{"issue":"4","key":"10.1016\/j.biopha.2021.111968_bib46","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.phrs.2010.05.002","article-title":"\u03b2-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain","volume":"62","author":"Buoso","year":"2010","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.biopha.2021.111968_bib47","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2021.111968_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5115\/acb.2016.49.1.1","article-title":"The association between PGC-1\u03b1 and Alzheimer\u2019s disease","volume":"49","author":"Sweeney","year":"2016","journal-title":"Anat. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111968_bib49","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archneurol.2008.588","article-title":"PGC-1\u03b1 expression decreases in the Alzheimer disease brain as a function of dementia","volume":"66","author":"Qin","year":"2009","journal-title":"Arch. Neurol."},{"issue":"5 Supplement 7","key":"10.1016\/j.biopha.2021.111968_bib50","first-page":"44","article-title":"FE65 serine-610 phosphorylation and its functional implications in Alzheimer disease amyloid precursor protein processing","volume":"25 Suppl 7","author":"Lau","year":"2019","journal-title":"Hong. Kong Med. J."},{"key":"10.1016\/j.biopha.2021.111968_bib51","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1007\/s00018-020-03467-1","article-title":"The Rab5 activator RME-6 is required for amyloid precursor protein endocytosis depending on the YTSI motif","volume":"77","author":"Eggert","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2021.111968_bib52","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1523\/JNEUROSCI.2501-19.2020","article-title":"Effect of A\u03b2 oligomers on neuronal APP triggers a vicious cycle leading to the propagation of synaptic plasticity alterations to healthy neurons","volume":"40","author":"Rolland","year":"2020","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"31","key":"10.1016\/j.biopha.2021.111968_bib53","doi-asserted-by":"crossref","first-page":"9704","DOI":"10.1523\/JNEUROSCI.2292-09.2009","article-title":"Synaptic activity reduces intraneuronal A\u03b2, promotes APP transport to synapses, and protects against A\u03b2-related synaptic alterations","volume":"29","author":"Tampellini","year":"2009","journal-title":"J. Neurosci."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221007502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221007502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:23:50Z","timestamp":1760099030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221007502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":53,"alternative-id":["S0753332221007502"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111968","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased P2\u00d72 receptors induced by amyloid-\u03b2 peptide participates in the neurotoxicity in alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111968"}}